We are testing a new immunotherapy, ABX-001, alone and with pembrolizumab for patients with tumors that have been treated before. The goal is to see if this combination can improve treatment outcomes.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced solid tumors are cancers that have spread beyond their original site and are no longer responding to standard treatments. This condition often requires specialized care and may be eligible for clinical trials exploring new therapies.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.